Registered entities
Acumen Pharmaceuticals, Inc
Reg. No. 36-4108129United States
Acumen Pharmaceuticals, Inc.
Reg. No. 1576885United States
ACUMEN PHARMACUETICALS INC
Reg. No. 364108129United States
ACUMEN EUROPE LTD
Reg. No. 14943610United Kingdom
Innovation
15 patent families (10 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace slowing. Cited 1,073 times.
| Year | Filings |
|---|---|
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Social engagement
Social engagement: 7.4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Private equity | 2 | 25% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 3 | 38% |
Recent activity
1 Jul 2026
Milestone
anniversary
16 Jun 2026
Partnership
JCR Pharmaceuticals
12 May 2026
Milestone